Artigo Acesso aberto

A COMPARISON OF THE EFFECTS OF IMIPRAMINE, TRIMIPRAMINE, AND SOME OTHER DRUGS IN RABBITS TREATED WITH A MONOAMINE OXIDASE INHIBITOR

1965; Wiley; Volume: 25; Issue: 1 Linguagem: Inglês

10.1111/j.1476-5381.1965.tb01768.x

ISSN

2056-8177

Autores

A. Loveless, Douglas Maxwell,

Tópico(s)

Animal Ecology and Behavior Studies

Resumo

British Journal of Pharmacology and ChemotherapyVolume 25, Issue 1 p. 158-170 Free Access A COMPARISON OF THE EFFECTS OF IMIPRAMINE, TRIMIPRAMINE, AND SOME OTHER DRUGS IN RABBITS TREATED WITH A MONOAMINE OXIDASE INHIBITOR A. H. LOVELESS, A. H. LOVELESS Research Laboratories, May & Baker Ltd., Dagenham, EssexSearch for more papers by this authorD. R. MAXWELL, D. R. MAXWELL Research Laboratories, May & Baker Ltd., Dagenham, EssexSearch for more papers by this author A. H. LOVELESS, A. H. LOVELESS Research Laboratories, May & Baker Ltd., Dagenham, EssexSearch for more papers by this authorD. R. MAXWELL, D. R. MAXWELL Research Laboratories, May & Baker Ltd., Dagenham, EssexSearch for more papers by this author First published: August 1965 https://doi.org/10.1111/j.1476-5381.1965.tb01768.xCitations: 26AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Asatoor, A. M., Levi, A. J. & Milne, M. D. (1963). Tranylcypromine and cheese. Lancet, ii, 733–734. Blackwell, B. (1963). Hypertensive crisis due to monoamine oxidase inhibitors. Lancet, ii, 849–851. Blackwell, B. & Marley, E. (1964). Interaction between cheese and monoamine oxidase inhibitors in rats and cats. Lancet, i, 530–531. Brachfield, J., Wirstshafter, A. & Wolfe, S. (1963). Imipramine-tranylcypromine incompatibility. Near fatal toxic reaction. J. Amer. med. Ass., 186, 1172–1173. Brodie, B. B., Spector, S. & Shore, P. A. (1959). Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain. Ann. N.Y. Acad. Sci., 80, 609–614. Brownlee, G. & Williams, G. W. (1963a). Potentiation of amphetamine and pethidine by monoamine oxidase inhibitors. Lancet, i, 669. Brownlee, G. & Williams, G. W. (1963b). Monoamine oxidase inhibitors. Lancet, i, 1323. Burford, H., Leick, J. & Walaszek, E. J. (1960). Modification of the effects of biogenic amines on the heart by iproniazid. Arch. int. Pharmacodyn., 128, 39–50. Burn, J. H. & Rand, M. J. (1958). The action of sympathomimetic amines in animals treated with reserpine. J. Physiol. (Lond), 144, 314–336. Committee on Safety of Drugs (1964). Monoamine oxidase inhibitors. Adverse Reactions Series No. 1. Cooper, K. E., Cranston, W. I. & Honour, A. J. (1964). Temperature changes induced by 5-HT, noradrenaline and pyrogens injected into the rabbit brain. J. Physiol. (Lond), 175, 68–69P. Crout, J. R., Creveling, C. R. & Udenfriend, S. (1961). Norepinephrine metabolism in rat brain and heart. J. Pharmacol, exp. Ther., 132, 269–277. Cuthill, J. M., Griffiths, A. B. & Powell, D. E. B. (1964). Death associated with tranylcypromine and cheese. Lancet, i, 1076–1077. Dally, P. J. (1962). Fatal reaction associated with tranylcypromine and methylamphetamine. Lancet, i, 1235–1236. Davies, G. (1960). Side effects of phenelzine. Brit. med. J., ii, 1019. Denton, P. H., Borrelli, V. M. & Edwards, N. V. (1962). Dangers of monoamine oxidase inhibitors. Brit. med. J., ii, 1752–1753. Feldberg, W. & Myers, R. D. (1964). Effects on temperature of amines injected into the cerebral ventricles. A new concept of temperature regulation. J. Physiol. (Lond), 173, 226–237. Fouts, J. R. & Brodie, B. B. (1956). On the mechanism of drug potentiation by iproniazid (2-isopropyl-1-isonicotinyl hydrazine). J. Pharmacol. exp. Ther., 116, 480–485. Göschke, H. (1961). Spezies-unterschiede bei der Wirkung von Monoaminoxydase Hemmern. Arch. int. Pharmacodyn., 133, 245–253. Green, H. & Erickson, R. W. (1960). Effect of trans-2-phenylcyclopropylamine upon norepinephrine concentration and monoamine oxidase activity of rat brain. J. Pharmacol, exp. Ther., 129, 237–242. Halliwell, G., Quinton, R. M. & Williams, F. E. (1964). A comparison of imipramine, chlorpromazine and related drugs in various tests involving autonomic functions and antagonism of reserpine. Brit. J. Pharmacol., 23, 330–350. Hiebel, G., Bonvallet, M., Huvé, P. & Dell, P. (1954). Analyse neurophysiologique de l'action centrale de la d-amphetamine (Maxiton). Sem. Hôp. Paris, 30, 1880–1887. Hodge, J. V., Nye, E. R. & Emerson, G. W. (1964). Monoamine oxidase inhibitors, broad beans, and hypertension. Lancet, i, 1108. Horita, A. (1959). Pharmacology of JB-516 (PIH). Ann. N.Y. Acad. Sci., 80, 590–595. Lambert, P. A. & Guyotat, J. (1961). Un nouvel antidépresseur sédatif dérivé de l'iminodibenzyle: Le 7162 R.P. Presse méd., 69, 1425. Laroche, M. & Brodie, B. B. (1960). Lack of relationship between inhibition of mono-amine oxidase and potentiation of hexobarbital hypnosis. J. Pharmacol, exp. Ther., 130, 134–137. Lee, F. I. (1961). Imipramine overdose—report of a fatal case. Brit. med. J., i, 338–339. Lehmann, H. E. & Ban, T. A. (1964). Notes from the log-book of a psychopharmacological research unit II. Canad. psychiat. Ass. J., 9, 111–113. Luby, E. D. & Domino, E. F. (1961). Toxicity from large doses of imipramine and monoamine oxidase inhibitor in suicidal intent. J. Amer. med. Ass., 177, 68–69. MacDonald, R. (1963). Tranylcypromine. Lancet, i, 269. Mason, A. (1962). Fatal reaction associated with tranylcypromine and methylamphetamine. Lancet, i, 1073. Maxwell, D. R. (1964). The relative potencies of various anti-depressant drugs in some laboratory tests. Neuropsychopharmacology, ed. P. B. Bradley, F. Flugel & P. Hoch, vol. 3, pp. 501–506. Amsterdam: Elsevier. Maxwell, D. R., Gray, W. R. & Taylor, E. M. (1961). Relative activity of some inhibitors of monoamine oxidase in potentiating the action of tryptamine in vitro and in vivo. Brit. J. Pharmacol., 17, 310–320. Natoff, I. L. (1964). Cheese and monoamine oxidase inhibitors—interaction in anaesthetized cats. Lancet, i, 532–533. Nymark, M. & Møller-Nielsen, I. (1963). Reactions due to the combination of monoamine oxidase inhibitors with thymoleptics, pethidine, or methylamphetamine. Lancet, ii, 524–525. Palmer, H. (1960). Potentiation of pethidine. Brit. med. J., ii, 944. Papp, C. & Benaim, S. (1958). Toxic effects of iproniazid in a patient with angina. Brit. med. J., ii, 1070–1072. Pletscher, A., Gey, K. F. & Zeller, P. (1960). Monoaminooxydase-Hemmer. In Progress in Drug Research, ed. E. Jucker, vol. 2, pp. 417–490. Basel: Birkhäuser Verlag. Pulver, R., Exer, B. & Herrmann, B. (1960). Einige Wirkungen des N-(γ-dimethylamino-propyl)-iminodibenzyl-HCl und seiner Metabolite auf den Stoffwechsel von Neurohormonen. Arzneimittel-Forsch., 10, 530–533. Rothballer, A. B. (1957). The effect of phenylephrine, methamphetamine, cocaine, and serotonin upon the adrenaline-sensitive component of the reticular activating system. Electroenceph. clin. Neurophysiol., 9, 409–417. Schaeppi, U. (1960). Die Beeinflussung der Reizübertragung im peripheren Sympathicus durch Tofranil. Helv. physiol. pharmacol. Acta, 18, 545–562. Serrone, D. M. & Fujimoto, J. M. (1960). Inhibition of the metabolism of hexobarbital in vitro. Biochem. Pharmacol., 5, 263–264. Shee, J. C. (1960). Dangerous potentiation of pethidine by iproniazid, and its treatment. Brit. med. J., ii, 507–508. Sigg, E. B. (1959). Pharmacological studies with Tofranil. Canad. psychiat. Ass. J., 4, S75–S83. Sigg, E. B. (1962). The pharmacodynamics of imipramine. In Psychosomatic Medicine, ed. J. H. Nodine & J. H. Moyer, pp. 671–678. London: Henry Kimpton. Singh, H. (1960). Atropine-like poisoning due to tranquilising agents. Amer. J. Psychiat., 117, 360–361. Spector, S. (1963). Mono-amine oxidase in control of brain serotonin and norepinephrine content. Ann. N.Y. Acad. Sci., 107, 856–861. Stanley, B. & Pal, N. R. (1964). Fatal hyperpyrexia with phenelzine and imipramine. Brit. med. J., ii, 1011. Sulser, F., Bickel, M. H. & Brodie, B. B. (1964). The action of desmethyl-imipramine in counteracting sedation and cholinergic effects of reserpine-like drugs. J. Pharmacol, exp. Ther., 144, 321–330. Sulser, F., Watts, J. & Brodie, B. B. (1962). On the mechanism of antidepressant action of imipramine-like drugs. Ann. N.Y. Acad. Sci., 96, 279–286. Taylor, D. C. (1962). Alarming reaction to pethidine in patients on phenelzine. Lancet, ii, 401–402. Vernier, V. G. (1961). The pharmacology of anti-depressant agents. Dis. Nerv. Syst., 22 (Sect. 2, suppl.), 7–13. Vernier, V. G., Hanson, H. M. & Stone, C. A. (1962). The pharmacodynamics of amitriptyline. In Psychosomatic Medicine, ed. J. H. Nodine & J. H. Moyer, pp. 683–690. London: Henry Kimpton. Citing Literature Volume25, Issue1August 1965Pages 158-170 ReferencesRelatedInformation

Referência(s)